CTXR
Price
$0.45
Change
+$0.05 (+12.50%)
Updated
Oct 26, 04:59 PM (EDT)
Capitalization
11.07M
52 days until earnings call
Intraday BUY SELL Signals
TELO
Price
$1.00
Change
+$0.03 (+3.09%)
Updated
Oct 26, 10:51 AM (EDT)
Capitalization
66.71M
14 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CTXR vs TELO

CTXR vs TELO Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CTXR vs. TELO commentary
Oct 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTXR is a Hold and TELO is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CTXR with price predictions
Oct 23, 2026

CTXR sees MACD Histogram just turned negative

CTXR saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 28, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 44 instances where the indicator turned negative. In 40 of the 44 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CTXR as a result. In 75 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.

CTXR moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTXR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for CTXR entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CTXR's RSI Oscillator exited the oversold zone, 37 of 43 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 17 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

CTXR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 44 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.166) is normal, around the industry mean (3.035). P/E Ratio (-0.231) is within average values for comparable stocks, (-1.360). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.535) among similar stocks. P/S Ratio (1.728) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. CTXR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTXR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for TELO with price predictions
Oct 23, 2026

TELO's RSI Indicator is remaining in oversold zone for 4 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3.42% 3-day Advance, the price is estimated to grow further. Considering data from situations where TELO advanced for three days, in 88 of 114 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

TELO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 24 of 41 cases where TELO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TELO as a result. In 48 of 51 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for TELO turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 28 similar instances when the indicator turned negative. In 26 of the 28 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

TELO moved below its 50-day moving average on October 07, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for TELO crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TELO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 48 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 80 (best 1 - 100 worst), indicating slightly worse than average price growth. TELO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.254) is normal, around the industry mean (3.035). P/E Ratio (-0.874) is within average values for comparable stocks, (-1.360). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.004) settles around the average of (133.535) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TELO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
CTXR: Fundamental Ratings
CTXR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
23
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTXRTELO
RSI
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
85%
Momentum
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 22 days ago
77%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
81%
Aroon
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
59%
COMPARISON
Comparison
Oct 26, 2026
Stock price -- (CTXR: $0.40 vs. TELO: $0.97)
Brand notoriety: CTXR and TELO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTXR: 142% vs. TELO: 60%
Market capitalization -- CTXR: $11.07M vs. TELO: $66.71M
CTXR [@Biotechnology] is valued at $11.07M. TELO’s [@Biotechnology] market capitalization is $66.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $132.8B. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTXR’s FA Score shows that 1 FA rating(s) are green while TELO’s FA Score has 0 green FA rating(s).

  • CTXR’s FA Score: 1 green, 4 red.
  • TELO’s FA Score: 0 green, 5 red.
According to our system of comparison, CTXR is a better buy in the long-term than TELO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTXR’s TA Score shows that 3 TA indicator(s) are bullish while TELO’s TA Score has 5 bullish TA indicator(s).

  • CTXR’s TA Score: 3 bullish, 5 bearish.
  • TELO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TELO is a better buy in the short-term than CTXR.

Price Growth

CTXR (@Biotechnology) experienced а -12.30% price change this week, while TELO (@Biotechnology) price change was -7.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.04%. For the same industry, the average monthly price growth was -12.59%, and the average quarterly price growth was -12.28%.

Reported Earning Dates

CTXR is expected to report earnings on Dec 17, 2026.

TELO is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Biotechnology (+5.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CTXR
Daily Signal:
Gain/Loss:
TELO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

CTXR and

Correlation & Price change

A.I.dvisor tells us that CTXR and ALEC have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTXR and ALEC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTXR
1D Price
Change %
CTXR100%
+8.79%
ALEC - CTXR
31%
Poorly correlated
N/A
MGX - CTXR
30%
Poorly correlated
-1.30%
TWST - CTXR
30%
Poorly correlated
+3.28%
PRQR - CTXR
29%
Poorly correlated
-3.01%
TELO - CTXR
28%
Poorly correlated
-3.96%
More

TELO and

Correlation & Price change

A.I.dvisor indicates that over the last year, TELO has been loosely correlated with DMRA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if TELO jumps, then DMRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TELO
1D Price
Change %
TELO100%
-3.96%
DMRA - TELO
35%
Loosely correlated
-2.86%
TWST - TELO
35%
Loosely correlated
+3.28%
LGND - TELO
31%
Poorly correlated
-1.39%
HYFT - TELO
30%
Poorly correlated
-3.33%
MGX - TELO
30%
Poorly correlated
-1.30%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABCL11.820.45
+3.96%
AbCellera Biologics
GDTC0.92N/A
N/A
CytoMed Therapeutics Limited
MINE2.39-0.01
-0.42%
Mayfair Gold Corp
HTLD10.18-0.11
-1.07%
Heartland Express
FOXA66.60-1.67
-2.45%
Fox Corp